Epigenetic Factors as Drivers of Fibrosis in Systemic Sclerosis

References

• Cutter AR , HayesJJ . A brief review of nucleosome structure . FEBS Lett.589 ( 20 Pt A ), 2914 – 2922 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kowalski A , PalygaJ . Modulation of chromatin function through linker histone H1 variants . Biol. Cell108 ( 12 ), 339 – 356 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ramming A , DistlerJH , SchettG , GayS , JungelA . Epigenetic modifications in autoimmune diseases . Z. Rheumatol.73 ( 7 ), 636 – 638 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Abraham DJ , KriegT , DistlerJ , DistlerO . Overview of pathogenesis of systemic sclerosis . Rheumatology (Oxford)48 ( Suppl. 3 ), iii3 – iii 7 ( 2009 ).
   PubMedGoogle Scholar
• Gabrielli A , AvvedimentoEV , KriegT . Scleroderma . N. Engl. J. Med.360 ( 19 ), 1989 – 2003 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Varga J , AbrahamD . Systemic sclerosis: a prototypic multisystem fibrotic disorder . J. Clin. Invest.117 ( 3 ), 557 – 567 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Nikpour M , BaronM . Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies . Curr. Opin. Rheumatol.26 ( 2 ), 131 – 137 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Abraham DJ , EckesB , RajkumarV , KriegT . New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma . Curr. Rheumatol. Rep.9 ( 2 ), 136 – 143 ( 2007 ).
   PubMedGoogle Scholar
• Wynn TA , RamalingamTR . Mechanisms of fibrosis: therapeutic translation for fibrotic disease . Nat. Med.18 ( 7 ), 1028 – 1040 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Distler JH , Feghali-BostwickC , SoareA , AsanoY , DistlerO , AbrahamDJ . Frontiers of antifibrotic therapy in systemic sclerosis . Arthritis Rheumatol. doi:10.1002/art.39865 ( 2016 ) ( Epub ahead of print ).
   Google Scholar
• Shi-Wen X , DentonCP , McwhirterAet al. Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis . Arthritis Rheum.40 ( 7 ), 1237 – 1244 ( 1997 ).
   PubMedGoogle Scholar
• Maxwell DB , GrotendorstCA , GrotendorstGR , LeroyEC . Fibroblast heterogeneity in scleroderma: Clq studies . J. Rheumatol.14 ( 4 ), 756 – 759 ( 1987 ).
   PubMed Web of Science ®Google Scholar
• Ludwicka A , TrojanowskaM , SmithEAet al. Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma . J. Rheumatol.19 ( 11 ), 1716 – 1723 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Keerthisingam CB , JenkinsRG , HarrisonNKet al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice . Am. J. Pathol.158 ( 4 ), 1411 – 1422 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Bechtel W , McgoohanS , ZeisbergEMet al. Methylation determines fibroblast activation and fibrogenesis in the kidney . Nat. Med.16 ( 5 ), 544 – 550 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Weber KT , BrillaCG . Factors associated with reactive and reparative fibrosis of the myocardium . Basic Res. Cardiol.87 ( Suppl. 1 ), 291 – 301 ( 1992 ).
   PubMedGoogle Scholar
• Rodemann HP , MullerGA . Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis . Am. J. Kidney Dis.17 ( 6 ), 684 – 686 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Mann J , MannDA . Epigenetic regulation of wound healing and fibrosis . Curr. Opin. Rheumatol.25 ( 1 ), 101 – 107 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lafyatis R . Epigenetics in systemic sclerosis . Arthritis Rheumatol.68 ( 12 ), 2841 – 2844 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Broen JC , RadstakeTR , RossatoM . The role of genetics and epigenetics in the pathogenesis of systemic sclerosis . Nat. Rev. Rheumatol.10 ( 11 ), 671 – 681 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Du J , JohnsonLM , JacobsenSE , PatelDJ . DNA methylation pathways and their crosstalk with histone methylation . Nat. Rev. Mol. Cell Biol.16 ( 9 ), 519 – 532 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hermann A , GowherH , JeltschA . Biochemistry and biology of mammalian DNA methyltransferases . Cell. Mol. Life Sci.61 ( 19–20 ), 2571 – 2587 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond . Nat. Rev. Genet.13 ( 7 ), 484 – 492 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Klein K , GayS . Epigenetics in rheumatoid arthritis . Curr. Opin. Rheumatol.27 ( 1 ), 76 – 82 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kaneda M , OkanoM , HataKet al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting . Nature429 ( 6994 ), 900 – 903 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Tahiliani M , KohKP , ShenYet al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 . Science324 ( 5929 ), 930 – 935 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Altorok N , TsouPS , CoitP , KhannaD , SawalhaAH . Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies . Ann. Rheum. Dis.74 ( 8 ), 1612 – 1620 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Huang SK , FisherAS , ScruggsAMet al. Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice . Am. J. Pathol.177 ( 5 ), 2245 – 2255 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Watson CJ , CollierP , TeaIet al. Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype . Hum. Mol. Genet.23 ( 8 ), 2176 – 2188 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wang Y , FanPS , KahalehB . Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts . Arthritis Rheum.54 ( 7 ), 2271 – 2279 ( 2006 ).
   PubMedGoogle Scholar
• Noda S , AsanoY , NishimuraSet al. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis . Nat. Commun.5 , 5797 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dees C , SchlottmannI , FunkeRet al. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis . Ann. Rheum. Dis.73 ( 6 ), 1232 – 1239 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dees C , AkhmetshinaA , BuschNet al. Inhibitors of DNA methyltransferases exert potent anti- fibrotic effects via re-activation of socs-3 . Ann. Rheum. Dis.8 ( Suppl. 3 ), 94 ( 2009 ).
   Google Scholar
• Kubo M , Czuwara-LadykowskaJ , MoussaOet al. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin . Am. J. Pathol.163 ( 2 ), 571 – 581 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Asano Y . Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis . Int. J. Biochem. Cell Biol.67 , 86 – 91 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Taniguchi T , AsanoY , AkamataKet al. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice . Arthritis Rheumatol.67 ( 2 ), 517 – 526 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Asano Y , BujorAM , TrojanowskaM . The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis . J. Dermatol. Sci.59 ( 3 ), 153 – 162 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Akhmetshina A , PalumboK , DeesCet al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis . Nat. Commun.3 , 735 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bergmann C , DistlerJH . Canonical Wnt signaling in systemic sclerosis . Lab. Invest.96 ( 2 ), 151 – 155 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Beyer C , SchrammA , AkhmetshinaAet al. β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis . Ann. Rheum. Dis.71 ( 5 ), 761 – 767 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chilosi M , PolettiV , ZamoAet al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis . Am. J. Pathol.162 ( 5 ), 1495 – 1502 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• He W , DaiC , LiY , ZengG , MongaSP , LiuY . Wnt/beta-catenin signaling promotes renal interstitial fibrosis . J. Am. Soc. Nephrol.20 ( 4 ), 765 – 776 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Henderson WR Jr , ChiEY , YeXet al. Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis . Proc. Natl Acad. Sci. USA107 ( 32 ), 14309 – 14314 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wei J , MelichianD , KomuraKet al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum. 63 ( 6 ), 1707 – 1717 ( 2011 ).
   PubMedGoogle Scholar
• Hamburg-Shields E , DinuoscioGJ , MullinNK , LafyatisR , AtitRP . Sustained beta-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes . J. Pathol.235 ( 5 ), 686 – 697 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bergmann C , AkhmetshinaA , DeesCet al. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway . Ann. Rheum. Dis.70 ( 12 ), 2191 – 2198 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Svegliati S , MarroneG , PezoneAet al. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis . Sci. Signal.7 ( 341 ), ra84 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Liongue C , SertoriR , WardAC . Evolution of cytokine receptor signaling . J. Immunol.197 ( 1 ), 11 – 18 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Dees C , TomcikM , Palumbo-ZerrKet al. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor beta in systemic sclerosis . Arthritis Rheum.64 ( 9 ), 3006 – 3015 ( 2012 ).
   PubMedGoogle Scholar
• Hugle T , O’reillyS , SimpsonRet al. Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts . Arthritis Rheum.65 ( 2 ), 481 – 491 ( 2013 ).
   PubMedGoogle Scholar
• O’reilly S , CiechomskaM , CantR , van LaarJM . Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via gremlin protein . J. Biol. Chem.289 ( 14 ), 9952 – 9960 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• O’donoghue RJ , KnightDA , RichardsCDet al. Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis . EMBO Mol. Med.4 ( 9 ), 939 – 951 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yin Y , LiuW , DaiY . SOCS3 and its role in associated diseases . Hum. Immunol.76 ( 10 ), 775 – 780 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hill GR , KunsRD , RaffeltNCet al. SOCS3 regulates graft-versus-host disease . Blood116 ( 2 ), 287 – 296 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lombardi LM , BakerSA , ZoghbiHY . MECP2 disorders: from the clinic to mice and back . J. Clin. Invest.125 ( 8 ), 2914 – 2923 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mann J , ChuDC , MaxwellAet al. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis . Gastroenterology138 ( 2 ), 705 – 714 ; 714 e701–e704 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• O’reilly S , CiechomskaM , FullardN , PrzyborskiS , Van LaarJM . IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics . Sci. Rep.6 , 25066 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Clapier CR , CairnsBR . The biology of chromatin remodeling complexes . Annu. Rev. Biochem.78 , 273 – 304 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bjerling P , SilversteinRA , ThonG , CaudyA , GrewalS , EkwallK . Functional divergence between histone deacetylases in fission yeast by distinct cellular localization and in vivo specificity . Mol. Cell. Biol.22 ( 7 ), 2170 – 2181 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Ghosh AK , BhattacharyyaS , WeiJet al. Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator . FASEB J.23 ( 9 ), 2968 – 2977 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ghosh AK , BhattacharyyaS , LakosG , ChenSJ , MoriY , VargaJ . Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma . Arthritis Rheum.50 ( 4 ), 1305 – 1318 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Huber LC , DistlerJH , MoritzFet al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis . Arthritis Rheum.56 ( 8 ), 2755 – 2764 ( 2007 ).
   PubMedGoogle Scholar
• Krämer M , DeesC , HuangJet al. Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis . Ann. Rheum. Dis.72 ( 4 ), 614 – 620 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bergmann C , BrandtA , DeesCet al. Jumonji domain containing protein 3 (JMJD3) as a novel epigenetic mechanism of fibroblast activation by regulation of Fra-2 . Arthritis Rheumatol.68 ( Suppl. 10 ), Abstract ( 2016 ).
   Google Scholar
• Barnes PJ , AdcockIM , ItoK . Histone acetylation and deacetylation: importance in inflammatory lung diseases . Eur. Respir. J.25 ( 3 ), 552 – 563 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• de Ruijter AJ , van GennipAH , CaronHN , KempS , van KuilenburgAB . Histone deacetylases (HDACs): characterization of the classical HDAC family . Biochem. J.370 ( Pt 3 ), 737 – 749 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S , GhoshAK , PannuJet al. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta . Arthritis Rheum.52 ( 4 ), 1248 – 1258 ( 2005 ).
   PubMedGoogle Scholar
• Sanders YY , HagoodJS , LiuH , ZhangW , AmbalavananN , ThannickalVJ . Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice . Eur. Respir. J.43 ( 5 ), 1448 – 1458 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Williams SM , Golden-MasonL , FergusonBSet al. Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes . J. Mol. Cell. Cardiol.67 , 112 – 125 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Van Beneden K , MannaertsI , PauwelsM , Van Den BrandenC , van GrunsvenLA . HDAC inhibitors in experimental liver and kidney fibrosis . Fibrogenesis Tissue Repair6 ( 1 ), 1 ( 2013 ).
   PubMedGoogle Scholar
• Tsou PS , WrenJD , AminMAet al. Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors . Arthritis Rheumatol. (Hoboken, NJ)68 ( 12 ), 2975 – 2985 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zerr P , Palumbo-ZerrK , HuangJet al. Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis . Ann. Rheum. Dis.75 ( 1 ), 226 – 233 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wei J , GhoshAK , ChuHet al. The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor beta signaling . Arthritis Rheumatol.67 ( 5 ), 1323 – 1334 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Akamata K , WeiJ , BhattacharyyaMet al. SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis . Oncotarget doi:10.18632/oncotarget.12504 ( 2016 ) ( Epub ahead of print ).
   PubMedGoogle Scholar
• Maurer B , DistlerJH , DistlerO . The Fra-2 transgenic mouse model of systemic sclerosis . Vascul. Pharmacol.58 ( 3 ), 194 – 201 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Soare A , RammingA , AvouacJ . Distler JHW. Updates on animal models of systemic sclerosis . J. Scleroderma Relat. Disord.1 ( 3 ), 241 – 316 ; e1–e3 ( 2016 ).
   Google Scholar
• Ciechomska M , O’reillyS , PrzyborskiS , OakleyF , Bogunia-KubikK , van LaarJM . Histone demethylation and toll-like receptor 8-dependent cross-talk in monocytes promotes transdifferentiation of fibroblasts in systemic sclerosis via Fra-2 . Arthritis Rheumatol.68 ( 6 ), 1493 – 1504 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Agger K , CloosPA , ChristensenJet al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development . Nature449 ( 7163 ), 731 – 734 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Hong S , ChoYW , YuLR , YuH , VeenstraTD , GeK . Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases . Proc. Natl Acad. Sci. USA104 ( 47 ), 18439 – 18444 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Eissenberg JC , ShilatifardA . Histone H3 lysine 4 (H3K4) methylation in development and differentiation . Dev. Biol.339 ( 2 ), 240 – 249 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Perugorria MJ , WilsonCL , ZeybelMet al. Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation . Hepatology56 ( 3 ), 1129 – 1139 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function . Cell116 ( 2 ), 281 – 297 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Vettori S , GayS , DistlerO . Role of microRNAs in fibrosis . Open Rheumatol. J.6 , 130 – 139 ( 2012 ).
   PubMedGoogle Scholar
• Maurer B , StanczykJ , JungelAet al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis . Arthritis Rheum.62 ( 6 ), 1733 – 1743 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Filipowicz W , BhattacharyyaSN , SonenbergN . Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nat. Rev. Genet.9 ( 2 ), 102 – 114 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• O’reilly S . MicroRNAs in fibrosis: opportunities and challenges . Arthritis Res. Ther.18 , 11 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ciechomska M , O’reillyS , SuwaraM , Bogunia-KubikK , Van LaarJM . MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-beta activated kinase 1 binding protein 1, implications for systemic sclerosis . PLoS ONE9 ( 12 ), e115596 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhu H , LiY , QuSet al. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma . J. Clin. Immunol.32 ( 3 ), 514 – 522 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Honda N , JinninM , Kira-EtohTet al. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin beta3 . Am. J. Pathol.182 ( 1 ), 206 – 216 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Honda N , JinninM , KajiharaIet al. TGF-beta-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts . J. Immunol.188 ( 7 ), 3323 – 3331 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Li H , YangR , FanXet al. MicroRNA array analysis of microRNAs related to systemic scleroderma . Rheumatol. Int.32 ( 2 ), 307 – 313 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Nakashima T , JinninM , YamaneKet al. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts . J. Immunol.188 ( 8 ), 3573 – 3583 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kajihara I , JinninM , YamaneKet al. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts . Am. J. Pathol.180 ( 2 ), 703 – 714 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Makino K , JinninM , HiranoAet al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma . J. Immunol.190 ( 8 ), 3905 – 3915 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yan Q , ChenJ , LiW , BaoC , FuQ . Targeting miR-155 to treat experimental scleroderma . Sci. Rep.6 , 20314 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Christmann RB , WootenA , Sampaio-BarrosPet al. miR-155 in the progression of lung fibrosis in systemic sclerosis . Arthritis Res. Ther.18 ( 1 ), 155 ( 2016 ).
   PubMedGoogle Scholar
• Cushing L , KuangPP , QianJet al. miR-29 is a major regulator of genes associated with pulmonary fibrosis . Am. J. Respir. Cell Mol. Biol.45 ( 2 ), 287 – 294 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Qin W , ChungAC , HuangXRet al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29 . J. Am. Soc. Nephrol.22 ( 8 ), 1462 – 1474 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liu Y , TaylorNE , LuLet al. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes . Hypertension55 ( 4 ), 974 – 982 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Chen HY , ZhongX , HuangXRet al. MicroRNA-29b inhibits diabetic nephropathy in db/db mice . Mol. Ther.22 ( 4 ), 842 – 853 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Van Rooij E , SutherlandLB , ThatcherJEet al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis . Proc. Natl Acad. Sci. USA105 ( 35 ), 13027 – 13032 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wuttge DM , CarlsenAL , TekuGet al. Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis . Rheumatology (Oxford)54 ( 11 ), 2100 – 2107 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Beermann J , PiccoliMT , ViereckJ , ThumT . Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches . Physiol. Rev.96 ( 4 ), 1297 – 1325 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Takenaka K , ChenBJ , ModesittSC , ByrneFL , HoehnKL , JanitzM . The emerging role of long non-coding RNAs in endometrial cancer . Cancer Genet.209 ( 10 ), 445 – 455 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Freedman JE , MianoJM . Challenges and opportunities in linking long noncoding rnas to cardiovascular, lung, and blood diseases . Arterioscler. Thromb. Vasc. Biol. doi:10.1161/atvbaha.116.308513 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Mira-Bontenbal H , GribnauJ . New Xist-interacting proteins in X-chromosome inactivation . Curr. Biol.26 ( 8 ), R338 – R342 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wang Z , JinninM , NakamuraKet al. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization . Exp. Dermatol.25 ( 2 ), 131 – 136 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Cohen AL , RayA , Van BrocklinMet al. A Phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors . Oncotarget doi:10.18632/oncotarget.14183 ( 2016 ) ( Epub ahead of print ).
   Google Scholar
• Scott LJ . Azacitidine: a review in myelodysplastic syndromes and acute myeloid leukaemia . Drugs76 ( 8 ), 889 – 900 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Blum W , SanfordBL , KlisovicRet al. Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a Phase 2 Cancer and Leukemia Group B Study (CALGB 10503) . Leukemia31 ( 1 ), 34 – 39 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Nieto M , DemolisP , BehanzinEet al. The European Medicines Agency Review of Decitabine (Dacogen) for the treatment of adult patients with acute myeloid leukemia: summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use . Oncologist21 ( 6 ), 692 – 700 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Issa JP , RobozG , RizzieriDet al. Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation Phase I study . Lancet Oncol.16 ( 9 ), 1099 – 1110 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Plummer R , VidalL , GriffinMet al. Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors . Clin. Cancer. Res.15 ( 9 ), 3177 – 3183 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Andrade AF , BorgesKS , SuazoVKet al. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma . Invest. New Drugs doi:10.1007/s10637-016-0401-4 ( 2016 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Gros C , FleuryL , NahoumVet al. New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors . J. Biol. Chem.290 ( 10 ), 6293 – 6302 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chen S , WangY , ZhouWet al. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening . J. Med. Chem.57 ( 21 ), 9028 – 9041 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Pechalrieu D , EtievantC , ArimondoPB . DNA methyltransferase inhibitors in cancer: from pharmacology to translational studies . Biochem. Pharmacol. doi:10.1016/j.bcp.2016.12.004 ( 2016 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Erdmann A , MenonY , GrosCet al. Design and synthesis of new non nucleoside inhibitors of DNMT3A . Bioorg. Med. Chem.23 ( 17 ), 5946 – 5953 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Castellano S , KuckD , VivianoMet al. Synthesis and biochemical evaluation of delta(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors . J. Med. Chem.54 ( 21 ), 7663 – 7677 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ceccaldi A , RajaveluA , RagozinSet al. Identification of novel inhibitors of DNA methylation by screening of a chemical library . ACS Chem. Biol.8 ( 3 ), 543 – 548 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Asgatay S , ChampionC , MarloieGet al. Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1 . J. Med. Chem.57 ( 2 ), 421 – 434 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kuck D , CaulfieldT , LykoF , Medina-FrancoJL . Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells . Mol. Cancer Ther.9 ( 11 ), 3015 – 3023 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Weng JR , LaiIL , YangHC , LinCN , BaiLY . Identification of kazinol Q, a natural product from Formosan plants, as an inhibitor of DNA methyltransferase . Phytother. Res.28 ( 1 ), 49 – 54 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Chistiakov DA , OrekhovAN , BobryshevYV . Treatment of cardiovascular pathology with epigenetically active agents: focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation . Int. J. Cardiol.227 , 66 – 82 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Makino K , JinninM , KajiharaIet al. Circulating miR-142–3p levels in patients with systemic sclerosis . Clin. Exp. Dermatol.37 ( 1 ), 34 – 39 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang Z , JinninM , KudoHet al. Detection of hair-microRNAs as the novel potent biomarker: evaluation of the usefulness for the diagnosis of scleroderma . J. Dermatol. Sci.72 ( 2 ), 134 – 141 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hardy T , ZeybelM , DayCPet al. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease . Gut doi:10.1136/gutjnl-2016-311526 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar